Trial Profile
A Study to Evaluate the Efficacy and Tolerability of Fingolimod and Dimethyl Fumarate in Patients With Multiple Sclerosis in Real World
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 23 Feb 2016 New trial record